ARCHIVES

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

February 23, 2007

In Brief: Longmire Reappointed to Panel; New Organ System Group For Brain-CNS Tumors Asked

April 26, 1985

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

Peter Jones begins term as AACR president-elect. New directors elected.

April 2, 2004

A Year at NCI: Harold Varmus Reflects On Provocative Questions, The Duke Scandal, Financial Disaster And Grant Review

July 22, 2011

Half Of Women Complete Full Hormone Therapy Regimen

July 30, 2010